Clinical trials
Recruiting Breast Neoplasms trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 7 |
| 2024 | 7 |
| 2025 | 17 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 41 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 5 |
| Merck Sharp & Dohme LLC | 4 |
| Novartis Pharmaceuticals | 4 |
| AstraZeneca | 3 |
| Daiichi Sankyo | 2 |
| Hoffmann-La Roche | 2 |
| NRG Oncology | 2 |
| Nagoya City University | 2 |
| Astellas Pharma Global Development, Inc. | 1 |
| Bayer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 41 |
| Ovarian Neoplasms | 9 |
| Endometrial Neoplasms | 8 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Stomach Neoplasms | 7 |
| Triple Negative Breast Neoplasms | 7 |
| Uterine Cervical Neoplasms | 6 |
| Colorectal Neoplasms | 5 |
| Esophageal Neoplasms | 5 |
| Prostatic Neoplasms | 4 |
Trials
Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.